Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study
The immunopathology of multiple sclerosis: an overview.
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate.
Glatiramer acetate ameliorates experimental autoimmune neuritis.
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
Alemtuzumab
Glatiramer acetate in the treatment of multiple sclerosis
Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder.
Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis.
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects.

Pages